Post Operative Infusion Pump Pain Study

NCT07349810 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Post Operative Pain

Interventions

DRUG: Bupivacaine 0.5% Injectable Solution
DRUG: Ropivacaine 0.2% Injectable Solution
DRUG: 1.3% liposomal bupivacaine (Exparel)
DEVICE: ambIT Infusion Pump

Sponsor

Rutgers, The State University of New Jersey